ZY 15121
Latest Information Update: 12 Aug 1994
At a glance
- Originator Novartis Consumer Health
- Class Antirheumatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders